CAPTRUST FINANCIAL ADVISORS - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 129 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q2 2022$5,000
+25.0%
409
+88.5%
0.00%
Q1 2022$4,000
+33.3%
217
+178.2%
0.00%
Q4 2021$3,0000.0%780.0%0.00%
Q3 2021$3,000780.00%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Karst Peak Capital Ltd 1,349,185$43,430,00078.86%
AIA Investment Management Private Ltd 354,035$11,396,0002.43%
Bellevue Group AG 400,029$12,877,0000.82%
Prince Street Capital Management LLC 81,400$2,620,0000.55%
PRUDENTIAL PLC 4,247,748$136,735,0000.44%
OppenheimerFunds, Inc. 2,936,797$94,536,0000.11%
SECTORAL ASSET MANAGEMENT INC 31,628$1,018,0000.11%
Tibra Equities Europe Ltd 27,900$898,0000.11%
Jabre Capital Partners S.A. 10,000$322,0000.11%
SCHRODER INVESTMENT MANAGEMENT GROUP 1,803,955$58,069,0000.10%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders